GHK-Cu / Copper Peptides: What Do They Actually Do for Skin and Hair?

Copper peptides sound like an ingredient that belongs in a laboratory rather than a bathroom cabinet. The idea behind them is fairly simple: attach copper to a small peptide and find out whether the combination changes how cells behave. GHK-Cu is the best known example. Laboratory research links it to the upkeep and rebuilding of the material around skin cells, which is a good reason to study it and no guarantee that every copper peptide product will make a visible difference. An interesting ingredient, a tested cosmetic formula and a proven medical treatment are three different things.

What is GHK-Cu?

GHK is a peptide of three amino acids, glycine, histidine and lysine, which is what the letters stand for. It occurs naturally in human plasma and was first isolated in 1973. When it binds copper, the complex is called GHK-Cu, and most of the biological activity is attributed to that complex rather than the bare peptide. GHK holds copper tightly enough to take it from albumin in the blood and loosely enough to pass it on to cells, so it works less like a conventional drug and more like a copper shuttle.

"Copper peptides" is a category, not one ingredient. Two products can both contain a copper peptide without containing the same molecule or having the same research behind them. It is like the difference between saying a product contains a vitamin and saying which vitamin: the category gets you started, and the identity tells you what you are actually judging.

Why are copper peptides used in skincare?

Much of the interest comes from research on fibroblasts, the cells that maintain the supporting material around them, including collagen, which gives skin its structure. In a 1988 laboratory study, GHK-Cu increased collagen production in fibroblast cultures In vitro ¹. That gave researchers a plausible reason to study it in skin repair.

Healthy tissue is not kept up by endlessly adding collagen, though. Old material also has to be broken down and replaced. A later cell study found GHK-Cu increased an enzyme involved in that turnover, matrix metalloproteinase 2, along with its natural inhibitors In vitro ². Interestingly, copper on its own had the same effect and the bare peptide did not. The point to take away is that researchers are studying tissue upkeep and remodelling, not a simple switch where more collagen means younger skin. A building needs repairs, new materials and careful removal of damaged parts; pouring more concrete everywhere would not make it a better building.

Most of the gene expression research that followed was written by the peptide's commercial developer ³. That does not make it wrong, but the mechanism has not been independently tested to the degree the volume of publication suggests.

The strongest human evidence is not cosmetic

The best human result for GHK-Cu is in wound healing. In 1994, a multicentre, randomised, evaluator blinded, placebo controlled trial tested a GHK-Cu gel on diabetic foot ulcers, with all patients on a standard care programme Human ⁴. Median ulcer closure was 98.5% with GHK-Cu against 60.8% with the inactive gel, and infection occurred in 7% against 34%. That is a substantial result on a hard clinical outcome. It is also more than thirty years old, was never followed by a confirming trial, and did not lead to an approved medicine.

What have human skin studies shown?

A small 2016 study tested a GHK-Cu serum carried in a lipid based delivery system Human ⁵. Forty women aged 40 to 65 used it twice a day for eight weeks, with a different product on each side of the face, and researchers measured one wrinkle near the corner of the eye. One woman stopped after a mild skin reaction, so results cover 39.

Against the inactive serum, wrinkle volume fell 55.8% and depth 32.8% more on the GHK-Cu side. Against a commercial Matrixyl product, volume fell 31.6% more, but the difference in depth was not significant. Those are useful early signals, with limits: the inactive serum lacked both the GHK-Cu and the delivery system, so the result cannot be credited to GHK-Cu alone; it measured one serum for eight weeks; and the serum was supplied by the company making it.

The best controlled published dermatological trial came out differently. People recovering from laser resurfacing around the mouth used skincare with or without a copper peptide product for 12 weeks, assessed by blinded evaluators and computer analysis Human ⁶. There was no significant difference between the groups on objective measures; only the patients' own questionnaire favoured the copper peptide. And the study most often quoted for copper peptide face creams, a 2002 study reported to show thicker skin and fewer fine lines in 71 women, is a conference abstract that cannot be found in PubMed or any other indexed database.

This is why the wording matters. "A formula improved a measured wrinkle" is much narrower than "copper peptides reverse skin ageing", and the second adds several conclusions no study has established.

Why the whole formula matters

Imagine two moisturisers that both highlight the same ingredient. One uses it in a formula close to the one tested in a study; the other has a different concentration, delivery system and set of supporting ingredients. It would be a mistake to assume both inherit the same results because the same word is on the label.

Getting through the skin is part of the problem. GHK-Cu is charged and water loving, and skin penetration studies find most of it stays in the outer layer rather than reaching the living skin where fibroblasts are In vitro ⁷. Delivery systems and fatty acid versions such as palmitoyl tripeptide-1 are attempts to fix that, which tells you the problem is real.

So the most useful question about a copper peptide serum is this: was the finished product tested, or is the brand pointing to research on an ingredient? Both can be informative, but they answer different questions. An ingredient study suggests a product is worth developing; a well designed trial of the finished product tells you more about what you might notice. A higher percentage on the packaging is not evidence of a better result without a proper comparison.

What does "improves skin" actually mean?

The phrase can hide a lot. A product might improve the look of one wrinkle, raise a laboratory measure of collagen, change how hydrated the skin is, or get good ratings from the people using it. Those are different outcomes. "People said their skin looked better" is a subjective rating. "Researchers measured a change in one wrinkle" is objective but narrow. "The product repaired damaged tissue" is a much bigger biological claim, and one does not establish the next. None of this is a reason to dismiss cosmetic improvements, which may matter a great deal to the person buying the product. It is a reason to describe the benefit honestly instead of turning a cosmetic observation into a claim about reversing ageing.

Does GHK-Cu help hair growth?

This is where the evidence gets mixed up most easily. A 2007 study often linked to copper peptides actually tested AHK-Cu, which has alanine where GHK-Cu has glycine In vitro ⁸. The researchers kept human hair follicles alive outside the body and grew cells from them, and AHK-Cu lengthened the follicles and increased cell growth under those conditions. It was not a trial in people with thinning hair, and it did not test GHK-Cu.

That leaves two gaps: a different peptide and a different setting. The study supports further research into a particular copper peptide in hair biology. It does not show that a GHK-Cu scalp product will regrow hair in people with pattern hair loss.

Human hair follicles are not a human hair loss trial

The word human can make a study sound further along than it is. Human cells in a laboratory are still laboratory research. They let scientists isolate a question and control the conditions, which is valuable, but they do not reproduce everything happening in a person. A convincing hair loss trial would need people with a clearly identified condition, a defined product, a proper comparison group and measurements such as hair density or standardised photographs over time. It would also report how many people dropped out, what side effects occurred and whether the improvements were big enough to matter outside a microscope. Those are not hurdles invented to make an interesting ingredient look bad. They are what it takes to turn "this affects follicles" into "this helps people with hair loss".

Hair loss is not one problem

A thinning crown, patchy hair loss and heavy shedding after an illness are not necessarily the same condition. The NHS lists causes including inherited pattern hair loss, illness, stress, cancer treatment, weight loss and iron deficiency ⁹. That makes a one size fits all "hair growth peptide" claim particularly unhelpful: even a genuinely effective treatment might help one type of hair loss and not another.

The NHS advises seeing a GP if you are worried about hair loss and getting an idea of the cause before going to a commercial hair clinic. It names established treatments for some forms of pattern hair loss, including minoxidil and, for men, finasteride. GHK-Cu should not be presented as an equivalent alternative just because its proposed mechanism sounds appealing.

Are GHK-Cu injections a stronger version of skincare?

No. Evidence from putting something on the skin cannot tell you what happens when it is injected. The US FDA's assessment of injectable GHK-Cu points to limited human safety data and a risk of immune reactions from clumping and impurities ¹⁰. It has since been moved off that FDA list because its nomination was withdrawn, a procedural step rather than a finding of safety. The assessment is specifically about injection and should not be read as saying ordinary copper peptide cosmetics are dangerous.

The reverse mistake matters just as much. Decades of topical use without a significant safety signal say nothing about an injectable preparation. Copper is a reactive metal that causes oxidative damage in excess, and there are no published human data on how injected GHK-Cu behaves in the body. Vials sold for research use have no verified sterility, purity or copper content. "More direct" is not a substitute for evidence about benefit and risk.

Regulatory status

In the UK, GHK-Cu is permitted as a cosmetic ingredient for use on the skin with cosmetic claims only. It has no MHRA marketing authorisation for any medical use, and injectable preparations are unlicensed medicines that cannot lawfully be supplied for human use. GHK-Cu also appears in the Glow and Klow peptide blends, which combine it with BPC-157, TB-500 and, in Klow, KPV; neither blend has been studied as a combination at all.

How to read copper peptide claims

Look for a clear link between the claim and the experiment. A skin cell study should be described as a skin cell study, a trial of one serum should name that formula, and a hair follicle experiment should not be presented as a successful treatment for baldness. Be especially cautious when an explanation jumps between these settings. A long list of references can still leave the central question unanswered: did researchers test the same thing, in the same way, for the benefit being claimed? That question is more useful than deciding copper peptides are either a miracle or meaningless.

The BioRx conclusion

GHK-Cu deserves a place in any serious discussion of cosmetic peptide research. Its laboratory findings give good reasons to study it, the old ulcer trial is a genuine result, and early formula specific skin results justify more research. None of that establishes every broader claim made about copper peptides. For hair, the task is to stop borrowing evidence from a related molecule or a follicle in a dish and presenting it as a proven GHK-Cu treatment. Interesting skin biology, early cosmetic evidence and convincing hair regrowth evidence are not the same thing.

Frequently asked questions

What is GHK-Cu?

A naturally occurring peptide of three amino acids (glycine, histidine, lysine) bound to copper, sold as copper peptide or copper tripeptide-1.

Does GHK-Cu work for wrinkles?

The evidence is mixed. A small 2016 study of one serum found reductions in a measured wrinkle, but the best controlled published trial, after laser treatment, found no objective difference, and the most quoted face cream study is an unpublished abstract.

Does GHK-Cu regrow hair?

That has not been shown. The study usually cited tested a different copper peptide, AHK-Cu, on hair follicles in a laboratory, not on people with hair loss.

Is GHK-Cu the same as GHK?

No. GHK is the bare peptide; GHK-Cu is the peptide bound to copper, and most of the proposed activity depends on the copper.

Is GHK-Cu legal in the UK?

As a cosmetic ingredient in products applied to the skin, yes. Injectable GHK-Cu is an unlicensed medicine and cannot lawfully be supplied for human use.

More peptide questions

References

Studies marked "View study in BioRx" sit in the clinical studies index with their design and evidence grade.

1. Maquart FX et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988;238:343-346
2. Siméon A et al. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci 2000;67:2257-2265
3. Pickart L, Margolina A (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences.PubMed · DOI · View study in BioRx
4. Mulder GD, Patt LM, Sanders L, Rosenstock J, Altman MI, Hanley ME, Duncan GW (1994). Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair and Regeneration.PubMed · DOI · View study in BioRx
5. Badenhorst T et al. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. J Aging Sci 2016;4(3):166
6. Miller TR et al. (2006). Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Archives of Facial Plastic Surgery.PubMed · DOI · View study in BioRx
7. Hostynek JJ et al. (2010). Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. Inflammation Research.PubMed · DOI · View study in BioRx
8. Pyo HK et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res 2007;30:834-839
9. NHS, Hair loss
10. FDA, Certain bulk drug substances for use in compounding that may present significant safety risks